Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?

Volume XXIII No. 15 - November 7, 2016

Test price data shows major difference between Medicare lab fee schedule and private payers

TDR Insider / By

This is an excerpt from a 1,500-word article in the November 7 issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group. CEO SUMMARY: THE DARK REPORT presents the lab industry’s first look at actual price …

Test price data shows major difference between Medicare lab fee schedule and private payers Read More »

To access this post, you must purchase The Dark Report.

Medicare Part B Lab Test Prices Versus Budgeted Payment

Commentary and Opinion by R. Lewis Dark / By

THERE IS AN IMPORTANT QUESTION THAT lab industry magazines and news sources have failed to address: How many years are left before Medicare officials drop fee-for-service payment for clinical lab testing? On January 26, 2015, the Department of Health and Human Services (HHS) issued a press release declaring an ambitious target. “HHS has set a goal of tying 30% of traditional, …

Medicare Part B Lab Test Prices Versus Budgeted Payment Read More »

To access this post, you must purchase The Dark Report.

10% PAMA Fee Cut Would Lower Medicare Pay to Laboratories by $400 Million

Laboratory Billing / By

CEO SUMMARY: Just eight weeks remain before certain clinical laboratories must begin submitting private payer lab test price data to the federal Centers for Medicare & Medicaid Services. A new report by the Office of the Inspector General makes it possible to estimate how CMS may implement fee cuts in 2018. THE DARK REPORT’s calculations show that a 10% …

10% PAMA Fee Cut Would Lower Medicare Pay to Laboratories by $400 Million Read More »

To access this post, you must purchase The Dark Report.

Labs Have Heavy Burden to Report Lab Price Data

Laboratory Billing / By

CEO SUMMARY: Clinical labs must assess their responsibilities to report lab test market prices to CMS as part of the Protecting Access to Medicare Act. A panel of three experts took up this topic at a recent webinar hosted by THE DARK REPORT. On June 23, the federal Centers for Medicaid & Medicare Services published …

Labs Have Heavy Burden to Report Lab Price Data Read More »

To access this post, you must purchase The Dark Report.

XIFIN Analysis of Its Real Price Data Shows Hospital Lab Price Effect

Laboratory Billing / By

CEO SUMMARY: In a new analysis of data its lab clients will use to report market prices to CMS, XIFIN Inc., reports private payers paid independent labs a weighted average price that was 19.6% less than what Medicare pays for 20 of its highest-volume tests. By contrast, private payers paid hospital labs with NPIs a weighted average …

XIFIN Analysis of Its Real Price Data Shows Hospital Lab Price Effect Read More »

To access this post, you must purchase The Dark Report.

Market Price Data Sample From: Independent Clinical Labs

Laboratory Billing / By

Here is the market price data for independent clinical labs from XIFIN Inc. Lâle White, Founder and CEO of XIFIN, discusses the data with THE DARK REPORT. EDITOR: When XIFIN analyzed the actual private payer price data that its independent clinical laboratory clients would report to CMS under the PAMA market price reporting rule, why did …

Market Price Data Sample From: Independent Clinical Labs Read More »

To access this post, you must purchase The Dark Report.

Market Price Data Sample from: Hospital Labs with NPI Numbers

Laboratory Billing / By

Here is the market price data for hospital labs with NPI numbers from XIFIN Inc. Lâle White, Founder and CEO of XIFIN, discusses the data with THE DARK REPORT. EDITOR: The analysis XIFIN has done of hospital lab market price data will be of high interest, not just in the lab industry, but also among legislators and …

Market Price Data Sample from: Hospital Labs with NPI Numbers Read More »

To access this post, you must purchase The Dark Report.

Market Price Data Sample from: Molecular/Genetic Labs

Laboratory Billing / By

Here is the market price data for molecular and genetic labs from XIFIN Inc. Lâle White, Founder and CEO of XIFIN, discusses the data with THE DARK REPORT. EDITOR: When you did this analysis of molecular and genetic testing labs, what caught your attention WHITE: The issue for us is that Medicare made significant cuts in molecular and genetic test …

Market Price Data Sample from: Molecular/Genetic Labs Read More »

To access this post, you must purchase The Dark Report.

Market Price Data Sample from: Pain Management/Toxicology Labs

Laboratory Billing / By

Here is the market price data for paint management and toxicology labs from XIFIN Inc. Lâle White, Founder and CEO of XIFIN, discusses the data with THE DARK REPORT. EDITOR: Before we discuss XIFIN’s analysis of what PAMA market price reporting will look like for labs involved in pain management testing and toxicology, I think it is appropriate to recognize …

Market Price Data Sample from: Pain Management/Toxicology Labs Read More »

To access this post, you must purchase The Dark Report.

Facebook-f Twitter Linkedin-in

The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: info@darkreport.com

© 2024 The Dark Report. All rights reserved.

;